Another lawmaker is taking on a pharmaceutical company for drug pricing. Source: BioSpace

AbbVie's investigational JAK1-inhibitor upadacitinib yielded positive top-line results in a Phase III trial as a monotherapy for rheumatoid arthritis patients. Source: BioSpace

Millendo Therapeutics announced that it has acquired Alize Pharma SAS in a stock-based transaction. Source: BioSpace

The parent company of JSR Life Sciences snapped up CRO Crown Bioscience International for $400M, the company announced this morning. Source: BioSpace

Under the seven-year nonexclusive licensing and supply agreement, Juno has obtained rights to use CTS Dynabeads CD3/CD28 magnetic beads as part of the clinical and commercial manufacturing processes for its…

Baillie Gifford and ORI Capital co-led the financing with significant new investments from Temasek and Cowen Healthcare Investments, alongside Juda Capital, Pavilion Capital, RTW Investments, Agent Capital, 4BIO Capital and…

Should you invest the way billionaire investors do? Source: BioSpace

The fact that Roche has separate R&D units has been the topic of second-guessing on the part of observers and analysts. Source: BioSpace

Array BioPharma announced today that it has entered into a clinical trial collaboration agreement with Pfizer to investigate the safety and efficacy of several novel anti-cancer combinations. Source: BioSpace

The round was co-led by funds managed by new investor Janus Henderson Investors. Source: BioSpace